Phase 3 Study of Finlndia Hair Lotion with Placebo Pill Versus Minoxidil and Finasteride for Treating Male Androgenetic Alopecia

What this Trial Is About

Researchers are evaluating the effectiveness of Finlndia hair lotion combined with oral treatment for men with androgenetic alopecia, a common form of hair loss. This Phase III clinical trial aims to compare this investigational lotion with a combination of minoxidil lotion and finasteride pills to understand which treatment better improves hair density. The study is sponsored by EMS and uses a randomized, double-blind, double-dummy design to ensure unbiased results. Participants will be assigned to one of two groups. One group will take an oral placebo pill and apply 1 mL of Finlndia hair lotion twice daily. The other group will take one oral finasteride pill daily and apply 1 mL of minoxidil lotion twice daily. This treatment period lasts six months, during which participants will follow these dosing schedules closely. During the study, participants hair density changes will be measured after six months to evaluate treatment effects. Researchers will also monitor and record any adverse events to assess safety. The study involves regular visits for assessments and adherence monitoring. The total participation time is six months, after which participants will complete the study evaluations.

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia